help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miaskiewicz, S. L.
Right arrow Articles by Verbalis, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miaskiewicz, S. L.
Right arrow Articles by Verbalis, J. G.

Journal of Clinical Endocrinology & Metabolism, Vol 68, 837-843, Copyright © 1989 by Endocrine Society


ARTICLES

Neurohypophyseal secretion in response to cholecystokinin but not meal- induced gastric distention in humans

SL Miaskiewicz, EM Stricker and JG Verbalis
Department of Medicine, University of Pittsburgh, Pennsylvania 15261.

Exogenous administration of cholecystokinin octapeptide (CCK) is known to decrease food intake and slow gastric emptying in humans and animals. Recent studies have shown that CCK stimulates neurohypophyseal secretion of oxytocin (OT) in rats and arginine vasopressin (AVP) in monkeys, and that gastric distention also stimulates OT release in rats. We therefore studied AVP and OT secretion in 14 normal subjects in response to meal-induced gastric distention and administration of CCK, both separately and in combination, to assess whether these stimuli similarly activated central neurohypophyseal pathways in humans. Neither plasma AVP nor OT concentrations increased after gastric distention produced by ingestion of a large meal. However, a dose-related increase in plasma AVP, but not OT levels, occurred after CCK administration, the threshold CCK dose being 0.05 micrograms/kg body weight. The AVP secretion in response to CCK administration was significantly correlated with subjective aversive symptoms quantified by use of a numeric scale (r = 0.61, P less than 0.001). In 12 of the 14 subjects plasma AVP levels increased in association with symptoms of epigastric pressure and discomfort before the onset of overt nausea or emesis. The combination of CCK and meal-induced gastric distention did not stimulate increases in plasma AVP levels in excess of those produced by CCK administration alone. The results demonstrate that AVP secretion resulting from emetic center activation often is a graded response that can begin in association with milder degrees of visceral discomfort before symptoms of overt nausea or emesis. In addition, the stimulation of AVP secretion by CCK administration, but not by meal- induced gastric distention in association with physiological satiety, suggests that some component of the anorectic effects of exogenous CCK in man likely results from activation of brainstem emetic centers.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. L. Feltrin, T. J. Little, J. H. Meyer, M. Horowitz, A. J. P. M. Smout, J. Wishart, A. N. Pilichiewicz, T. Rades, I. M. Chapman, and C. Feinle-Bisset
Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R524 - R533.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Lal, J. McLaughlin, J. Barlow, M. D'Amato, G. Giacovelli, A. Varro, G. J. Dockray, and D. G. Thompson
Cholecystokinin pathways modulate sensations induced by gastric distension in humans
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G72 - G79.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Rinaman
Hindbrain Noradrenergic Lesions Attenuate Anorexia and Alter Central cFos Expression in Rats after Gastric Viscerosensory Stimulation
J. Neurosci., November 5, 2003; 23(31): 10084 - 10092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. C. Mantella, L. Rinaman, R. R. Vollmer, and J. A. Amico
Cholecystokinin and D-fenfluramine inhibit food intake in oxytocin-deficient mice
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1037 - R1045.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
I. Billig, B. J. Yates, and L. Rinaman
Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1243 - R1255.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Gimpl and F. Fahrenholz
The Oxytocin Receptor System: Structure, Function, and Regulation
Physiol Rev, April 1, 2001; 81(2): 629 - 683.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C Feinle, O Meier, B Otto, M D'Amato, and M Fried
Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia
Gut, March 1, 2001; 48(3): 347 - 355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Feinle, D. Grundy, B. Otto, and M. Fried
Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1217 - R1223.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society